Nike Appoints David Denton as New CFO, Matthew Friend to Transition
NKE is trading near its 52-week low of $41.35 (3.5% above the low).
Summary
Nike announced a new Chief Financial Officer, David Denton, effective August 16, 2026, replacing Matthew Friend, who will transition to an advisory role. The company also provided a preliminary Q4 fiscal 2026 financial update, expecting results to be generally in line with guidance, aided by a tariff refund.
Key Events · Executive and Board Changes · NKE
-
New Chief Financial Officer Appointed
David Denton, formerly CFO of Pfizer and Lowe's, has been appointed Executive Vice President and Chief Financial Officer, effective August 16, 2026. His compensation package includes an annual base salary of $1,450,000, a target annual bonus of 120% of base salary, and an annual target long-term incentive award of $11,500,000. He will also receive one-time cash awards totaling $11,250,000 to compensate for forfeited prior compensation.
-
Outgoing CFO Transition
Matthew Friend will step down as Executive Vice President and CFO on August 16, 2026, and will serve as an advisor to the CEO until his separation on September 4, 2026. His transition was not due to any disagreement with management. He will receive a lump sum transition benefit of $2,000,000 and severance benefits under the new Executive Severance Pay Plan.
-
Preliminary Q4 Financial Update
Nike provided preliminary information for its fiscal fourth quarter ended May 31, 2026. The company expects results to be generally in line with previously provided guidance, excluding a one-time benefit from tariff refunds. Full Q4 and fiscal year 2026 results are scheduled to be reported on June 30, 2026.
-
Executive Severance Plan Adopted
The Board of Directors approved and adopted the NIKE, Inc. Executive Severance Pay Plan, effective June 16, 2026. This plan standardizes severance benefits for eligible U.S. employees designated as Compensation Grade 70 or above upon involuntary termination without cause.
Analysis · NKE · Manufacturing
Nike is making a significant leadership change by appointing David Denton, a seasoned CFO from Pfizer and Lowe's, to lead its global finance organization. This move is particularly important given Nike's recent struggles, including declining profits, halted share buybacks, and a negative sales outlook, with the stock trading near 52-week lows. Bringing in an executive with over 30 years of experience signals a focused effort to improve financial discipline and navigate the company's restructuring. The preliminary Q4 results, while generally in line with previous guidance (excluding a one-time tariff refund benefit), avoid further negative surprises, which could be a relief to investors amidst the ongoing challenges.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NKE was trading at $42.80 on NYSE in the Manufacturing sector, with a market capitalization of approximately $62.8B. The 52-week trading range was $41.35 to $80.17. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.